PBAC

PBS recommendations for bimekizumab, guselkumab

Eli Lilly pulls PBS application for eczema drug

Eli Lilly exec says slow PBS threatens clinical trials funding

Atopic dermatitis drug gets PBAC support

PBAC tick for new psoriasis, HS and AD options

Shingrix to be funded from 1 November
